fluorescein-5-isothiocyanate has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, QH; Tang, W; Wang, BL; Wang, P; Wang, XB; Zhang, K | 1 |
| Iguchi, S; Kaneo, Y; Shiramoto, S; Tanaka, T | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and Sarcoma 180
| Article | Year |
|---|---|
Enhancement of apoptosis by sonodynamic therapy with protoporphyrin IX in isolate sarcoma 180 cells.
Topics: Animals; Annexin A5; Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Separation; Collagen Type XI; Enzyme Activation; Fluorescein-5-isothiocyanate; Mice; Mice, Inbred ICR; Protoporphyrins; Sarcoma 180; Ultrasonics | 2008 |
The disposition of serum proteins as drug-carriers in mice bearing Sarcoma 180.
Topics: Anhydrides; Animals; Blood Proteins; Drug Carriers; Feces; Fluorescein-5-isothiocyanate; Glutarates; Mice; Sarcoma 180; Tissue Distribution | 1993 |